Production (Stage)
LeMaitre Vascular, Inc.
LMAT
$81.40
$2.282.88%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 226.26M | 219.86M | 213.03M | 205.62M | 199.89M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 226.26M | 219.86M | 213.03M | 205.62M | 199.89M |
| Cost of Revenue | 70.60M | 68.96M | 67.45M | 66.41M | 67.06M |
| Gross Profit | 155.66M | 150.90M | 145.58M | 139.21M | 132.83M |
| SG&A Expenses | 87.00M | 83.00M | 79.59M | 76.62M | 74.76M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 173.25M | 167.61M | 163.42M | 159.98M | 159.00M |
| Operating Income | 53.01M | 52.26M | 49.61M | 45.64M | 40.89M |
| Income Before Tax | 58.32M | 56.88M | 54.17M | 49.44M | 44.26M |
| Income Tax Expenses | 13.16M | 12.84M | 12.85M | 11.76M | 10.30M |
| Earnings from Continuing Operations | 45.16 | 44.04 | 41.32 | 37.68 | 33.95 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 45.16M | 44.04M | 41.32M | 37.68M | 33.95M |
| EBIT | 53.01M | 52.26M | 49.61M | 45.64M | 40.89M |
| EBITDA | 62.85M | 61.93M | 59.24M | 55.24M | 50.44M |
| EPS Basic | 2.01 | 1.96 | 1.84 | 1.69 | 1.52 |
| Normalized Basic EPS | 1.62 | 1.58 | 1.51 | 1.38 | 1.25 |
| EPS Diluted | 1.97 | 1.93 | 1.82 | 1.66 | 1.50 |
| Normalized Diluted EPS | 1.60 | 1.56 | 1.49 | 1.37 | 1.23 |
| Average Basic Shares Outstanding | 90.01M | 89.81M | 89.58M | 89.36M | 89.12M |
| Average Diluted Shares Outstanding | 91.36M | 91.03M | 90.59M | 90.24M | 89.96M |
| Dividend Per Share | 0.68 | 0.64 | 0.62 | 0.60 | 0.58 |
| Payout Ratio | 33.89% | 32.65% | 33.63% | 35.60% | 38.11% |